当前位置:首页 - 行情中心 - 拓新药业(301089) - 财务分析 - 现金流量表

拓新药业

(301089)

  

流通市值:24.22亿  总市值:33.88亿
流通股本:9047.01万   总股本:1.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金81,824,745.02279,456,032.62229,605,482.71149,408,894.76
  收到的税费返还1,099,914.556,329,215.115,815,039.314,085,687.95
  收到其他与经营活动有关的现金755,531.6824,452,838.9510,321,516.67,552,218.36
  经营活动现金流入小计83,680,191.25310,238,086.68245,742,038.62161,046,801.07
  购买商品、接受劳务支付的现金38,778,473.95121,589,748.24111,190,316.2173,059,052.87
  支付给职工以及为职工支付的现金35,849,925.96139,856,823.74106,136,972.9472,686,028.32
  支付的各项税费3,994,937.7223,625,697.5217,027,745.3614,427,513.12
  支付其他与经营活动有关的现金6,466,357.8451,352,718.2134,176,587.4923,888,841.86
  经营活动现金流出小计85,089,695.47336,424,987.71268,531,622184,061,436.17
  经营活动产生的现金流量净额-1,409,504.22-26,186,901.03-22,789,583.38-23,014,635.1
二、投资活动产生的现金流量:
  收回投资收到的现金75,347,366.39984,823,350.64725,000,000470,000,000
  取得投资收益收到的现金-172,197.63,911,595.042,578,804.38
  投资活动现金流入小计75,347,366.39984,995,548.24728,911,595.04472,578,804.38
  购建固定资产、无形资产和其他长期资产支付的现金6,877,871.0244,454,904.4234,571,342.5418,597,614.98
  投资支付的现金60,000,000870,000,000670,000,000435,000,000
  投资活动现金流出小计66,877,871.02914,454,904.42704,571,342.54453,597,614.98
  投资活动产生的现金流量净额8,469,495.3770,540,643.8224,340,252.518,981,189.4
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金51,785.414,167.01--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计51,785.414,167.01--
  支付其他与筹资活动有关的现金-1,224,188.161,224,188.16-
  筹资活动现金流出平衡项目-00-
  筹资活动现金流出小计-1,224,188.161,224,188.16-
  筹资活动产生的现金流量净额平衡项目000-
  筹资活动产生的现金流量净额51,785.4-1,210,021.15-1,224,188.16-
四、汇率变动对现金及现金等价物的影响-290,232-287,930.55-154,322.2131,607.96
五、现金及现金等价物净增加额6,821,544.5542,855,791.09172,158.76-3,901,837.74
  加:期初现金及现金等价物余额104,637,524.3461,781,733.2561,781,733.2561,781,733.25
  期末现金及现金等价物余额111,459,068.89104,637,524.3461,953,892.0157,879,895.51
补充资料:
  净利润--69,661,027.7--18,280,549.55
  资产减值准备-16,116,367.19-7,316,298.7
  固定资产和投资性房地产折旧-62,432,781.88-23,902,641.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-62,432,781.88-23,902,641.19
  无形资产摊销-2,881,512.27-1,395,802.04
  长期待摊费用摊销-876,477.19-434,141.28
  固定资产报废损失-416,386.26-277,289.27
  公允价值变动损失--147,519.18--755,247.22
  财务费用-428,331.08--54,910.49
  投资损失--4,119,715.12--1,703,047.95
  递延所得税--3,684,929.54--3,455,836.94
  其中:递延所得税资产减少--1,398,308.88--2,916,489.5
    递延所得税负债增加--2,286,620.66--539,347.44
  存货的减少--15,354,588.77--13,811,386.09
  经营性应收项目的减少--15,069,455.3--31,143,139.3
  经营性应付项目的增加--14,447,074.37-13,367,576
  现金的期末余额-104,637,524.34-57,879,895.51
  减:现金的期初余额-61,781,733.25-61,781,733.25
  现金及现金等价物的净增加额-42,855,791.09--3,901,837.74
公告日期2026-04-282026-03-282025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑